New drugs take too long to get to market because of clinical trial bottlenecks. Two cancer doctors built AI-enabled tech to speed up the process. As longtime cancer doctors with regulatory experience, ...

DUBLIN--(BUSINESS WIRE)--ICON plc, (NASDAQ: ICLR) a world-leading clinical research organisation powered by healthcare intelligence, today announced the expansion of its portfolio of artificial ...

General Catalyst has led a $67 million series B funding round for digital clinical trials startup Vial. The company offers software platforms that digitize the clinical trial process, including ...

New Release of Advarra's Study Collaboration Solution Provides Sponsors and CROs a Single View into the Progress of Site Activation Milestones and IRB Review Status Across Sites COLUMBIA, Md., April ...

Drugs are man-made miracles. They enhance our health, cure diseases, and extend our lives. However, drug development is not easy. It is a remarkably long, expensive, and complex process. On average, ...

With a commitment to process optimization, training, and audits to enhance their operations, CROs can ensure the integrity of medications throughout the trial process. The Fast Company Executive Board ...

For a drugmaker advancing medicines through clinical trials, time is the enemy: the longer the process takes, the more costs rise. Newly formed Dash Bio says it has a solution. Dash aims to help drug ...

This analysis is by Bloomberg Intelligence Industry Analyst Andrew Galler and Senior Associate Analyst Jack Maltby. It appeared first on the Bloomberg Terminal. Clinical trials represent a significant ...

Many clinical trials include a placebo group—participants who receive an inactive treatment—so researchers can compare ...